EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Cannabis vaporisation: Understanding products, devices and risks

Caroline A MacCallum iD, Lindsay A Lo, Carly A Pistawka, April Christiansen, Michael Boivin

Drug and Alcohol Review · 2024-03 · 43 (3) · 732-745

DOI: 10.1111/dar.13800 ↗

At a glance

Übersichtsarbeit in Drug and Alcohol Review, published online on 2023-12-20. Written by Caroline A MacCallum and 4 co-authors. Institution: Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada. Major MEDLINE topics: Cannabis, Hallucinogens. Cited 30 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Issues Vaporisation is a common method of cannabis administration. Inconsistent terminology and jargon regarding vaporisation has led to confusion. The increasing public interest and access to cannabis, combined with possible safety concerns associated with certain cannabis vaping products, warrants improved consumer and public and health care professional knowledge. Approach To improve this knowledge, we conducted a review of the common terminology, regulatory status, products and device types related to cannabis vaporisation. Key Findings Cannabis vaporisation devices can be separated into nine types. While vaporisation reduces respiratory risks associated with cannabis combustion, not all vaping products and device types carry the same level of safety. Metered dose inhalers and dried product vaporisers present the lowest safety risk due to a lower risk of toxin exposure and the use of lower tetrahydrocannabinol potency products.

Implications

As both vaping and cannabis use increase in popularity, focusing on accurate health education will help facilitate health promotion to encourage lower risk use. The current lack of understanding on risk differences between types of cannabis vaporisation is a missed opportunity for harm reduction. Increased opportunities for public health and health care professional education on different cannabis vaporisation devices and associated risks are warranted. Improvements to health warning labelling may also be beneficial.

Conclusion

Not all cannabis vaporisation devices and products carry the same level of risk. A better understanding of risk differentiation is needed among consumers and health professionals. Continued research, policy development and health education can lead to safer cannabis vaporisation.

Subjects

MeSH terms (MEDLINE)

CannabisHallucinogensHumansVolatilizationDronabinolHarm Reduction

Author keywords

cannabiscannabis concentratese-cigarettehealth educationvapingvaporisation

Substances

HallucinogensDronabinol

Authors and institutions

  • Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Department of Public Health Science, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Faculty of Science, University of British Columbia, Vancouver, Canada.
  • Six Degrees Medical, Vancouver, Canada.
  • CommPharm Consulting, Barrie, Canada.

ORCID profiles: Caroline A MacCallum

Cite

APA

MacCallum, C. A., Lo, L. A., Pistawka, C. A., Christiansen, A., & Boivin, M. (2024). Cannabis vaporisation: Understanding products, devices and risks. Drug and Alcohol Review, 43(3), 732-745. https://doi.org/10.1111/dar.13800

Vancouver

MacCallum CA, Lo LA, Pistawka CA, Christiansen A, Boivin M. Cannabis vaporisation: Understanding products, devices and risks. Drug and Alcohol Review. 2024;43(3):732-745. doi:10.1111/dar.13800

BibTeX
@article{MacCallum2024,
  author = {MacCallum, Caroline A and Lo, Lindsay A and Pistawka, Carly A and Christiansen, April and Boivin, Michael},
  title = {Cannabis vaporisation: Understanding products, devices and risks},
  journal = {Drug and Alcohol Review},
  year = {2024},
  volume = {43},
  number = {3},
  pages = {732--745},
  doi = {10.1111/dar.13800}
}
Start for free →